Document Detail


The detection of minimal residual disease in acute lymphoblastic leukaemia.
MedLine Citation:
PMID:  1633509     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The detection of minimal residual disease in acute lymphoblastic leukaemia (ALL) can be achieved by assessing leukaemia-specific features at a cellular, chromosomal or molecular level. The application of the polymerase chain reaction to the amplification of leukaemia-specific chromosomal translocations and clone-specific immunoglobulin and T-cell receptor gene rearrangements allows assessment of the majority of cases of ALL. The sensitivity of detection of this technique is around one leukaemia cell in 10(5) normal marrow cells. A comparative review of the advantages and pitfalls of the different methods of detecting minimal disease is presented. The clinical relevance of such detection is discussed, with early results suggesting that this may have predictive value for future disease relapse.
Authors:
M N Potter
Related Documents :
2724649 - Basophilic crisis of chronic myelogenous leukemia.
6940519 - Meningeal involvement in philadelphia chromosome-negative chronic granulocytic leukemia.
6967249 - Clinical and experimental studies on the incorporation of materials applied as covering...
12691999 - Recsim and indstats: probabilities of identity in general genealogies.
8497319 - In utero rearrangements in the trithorax-related oncogene in infant leukaemias.
12270649 - Frequencies of the g-protein beta3 subunit c825t polymorphism and the delta 32 mutation...
8528209 - Mapping of genes predisposing to idiopathic generalized epilepsy.
19130129 - Canine rd3 mutation establishes rod-cone dysplasia type 2 (rcd2) as ortholog of human a...
6877239 - Deletion and amplification of the hgprt locus in chinese hamster cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  Blood reviews     Volume:  6     ISSN:  0268-960X     ISO Abbreviation:  Blood Rev.     Publication Date:  1992 Jun 
Date Detail:
Created Date:  1992-08-26     Completed Date:  1992-08-26     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8708558     Medline TA:  Blood Rev     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  68-82     Citation Subset:  IM    
Affiliation:
Department of Haematology-Oncology, Royal Hospital for Sick Children, Bristol, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Immunoglobulin Heavy Chains / genetics
Mutation
Polymerase Chain Reaction
Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*,  genetics,  pathology
Receptors, Antigen, T-Cell / genetics
Translocation, Genetic / genetics
Chemical
Reg. No./Substance:
0/Immunoglobulin Heavy Chains; 0/Receptors, Antigen, T-Cell

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Transcription factors, translocations and haematological malignancies.
Next Document:  Platelet-neutrophil interactions: their significance.